TOX As a Potential Target for Immunotherapy in Lymphocytic Malignancies

Overview

Journal Biomark Res

Publisher Biomed Central

Date 2021 Mar 21

PMID 33743809

Citations 30

Authors

Chaofeng Liang

Shuxin Huang

Yujie Zhao

Shaohua Chen

Yangqiu Li

Affiliations

Soon will be listed here.

Abstract

TOX (thymocyte selection-associated HMG BOX) is a member of a family of transcriptional factors that contain the highly conserved high mobility group box (HMG-box) region. Increasing studies have shown that TOX is involved in maintaining tumors and promoting T cell exhaustion. In this review, we summarized the biological functions of TOX and its contribution as related to lymphocytic malignancies. We also discussed the potential role of TOX as an immune biomarker and target in immunotherapy for hematological malignancies.

Citing Articles

Understanding genetic variations associated with familial breast cancer.

Pal M, Das D, Pandey M World J Surg Oncol. 2024; 22(1):271.

PMID: 39390525 PMC: 11465949. DOI: 10.1186/s12957-024-03553-9.

Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion.

Fiorenza S, Zheng Y, Purushe J, Bock T, Sarthy J, Janssens D Nat Commun. 2024; 15(1):8309.

PMID: 39333103 PMC: 11436946. DOI: 10.1038/s41467-024-52503-2.

CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8 T cells via JAK2/STAT3 pathway.

Cao C, Xu M, Wei Y, Peng T, Lin S, Liu X Cell Genom. 2024; 4(10):100659.

PMID: 39317187 PMC: 11602566. DOI: 10.1016/j.xgen.2024.100659.

Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons-A Comprehensive Review.

Krsek A, Ostojic L, Zivalj D, Baticic L Int J Mol Sci. 2024; 25(17).

PMID: 39273641 PMC: 11396210. DOI: 10.3390/ijms25179695.

Exhaustion of T cells after renal transplantation.

Wang X, Zhang J, Zhong P, Wei X Front Immunol. 2024; 15:1418238.

PMID: 39165360 PMC: 11333218. DOI: 10.3389/fimmu.2024.1418238.

References

Schwindt H, Vater I, Kreuz M, Montesinos-Rongen M, Brunn A, Richter J . Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma. Leukemia. 2009; 23(10):1875-84. DOI: 10.1038/leu.2009.120. View

Lee C, Ito K, Ito Y . Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer. Cancer Res. 2010; 70(10):4243-52. DOI: 10.1158/0008-5472.CAN-09-3805. View

Aliahmad P, Seksenyan A, Kaye J . The many roles of TOX in the immune system. Curr Opin Immunol. 2012; 24(2):173-7. PMC: 3319641. DOI: 10.1016/j.coi.2011.12.001. View

Aliahmad P, Kaye J . Development of all CD4 T lineages requires nuclear factor TOX. J Exp Med. 2008; 205(1):245-56. PMC: 2234360. DOI: 10.1084/jem.20071944. View

Vanheer L, Song J, De Geest N, Janiszewski A, Talon I, Provenzano C . Tox4 modulates cell fate reprogramming. J Cell Sci. 2019; 132(20). PMC: 6826012. DOI: 10.1242/jcs.232223. View

Yuan S, Qiu Z, Ghosh A . TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci U S A. 2009; 106(8):2909-14. PMC: 2650364. DOI: 10.1073/pnas.0805555106. View

Safavi S, Hansson M, Karlsson K, Biloglav A, Johansson B, Paulsson K . Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia. Haematologica. 2014; 100(1):55-61. PMC: 4281313. DOI: 10.3324/haematol.2014.112912. View

Hosking B, Wyeth J, Pennisi D, Wang S, Koopman P, Muscat G . Cloning and functional analysis of the Sry-related HMG box gene, Sox18. Gene. 2001; 262(1-2):239-47. DOI: 10.1016/s0378-1119(00)00525-4. View

Aliahmad P, Torre B, Kaye J . Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat Immunol. 2010; 11(10):945-52. PMC: 2943551. DOI: 10.1038/ni.1930. View

10.

Khan O, Giles J, McDonald S, Manne S, Ngiow S, Patel K . TOX transcriptionally and epigenetically programs CD8 T cell exhaustion. Nature. 2019; 571(7764):211-218. PMC: 6713202. DOI: 10.1038/s41586-019-1325-x. View

11.

Bowles J, Schepers G, Koopman P . Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol. 2000; 227(2):239-55. DOI: 10.1006/dbio.2000.9883. View

12.

Han Y, Liang D . The role of the tumor suppressor RUNX3 in giant cell tumor of the bone. Int J Oncol. 2011; 40(3):673-8. DOI: 10.3892/ijo.2011.1249. View

13.

Jin S, Yang Z, Hao X, Tang W, Ma W, Zong H . Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment. Biomark Res. 2020; 8:21. PMC: 7298841. DOI: 10.1186/s40364-020-00201-8. View

14.

Scott A, Dundar F, Zumbo P, Chandran S, Klebanoff C, Shakiba M . TOX is a critical regulator of tumour-specific T cell differentiation. Nature. 2019; 571(7764):270-274. PMC: 7698992. DOI: 10.1038/s41586-019-1324-y. View

15.

Stros M . HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta. 2010; 1799(1-2):101-13. DOI: 10.1016/j.bbagrm.2009.09.008. View

16.

Seo H, Chen J, Gonzalez-Avalos E, Samaniego-Castruita D, Das A, Wang Y . TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8 T cell exhaustion. Proc Natl Acad Sci U S A. 2019; 116(25):12410-12415. PMC: 6589758. DOI: 10.1073/pnas.1905675116. View

17.

Chen C, Liang C, Wang S, Chio C, Zhang Y, Zeng C . Expression patterns of immune checkpoints in acute myeloid leukemia. J Hematol Oncol. 2020; 13(1):28. PMC: 7118887. DOI: 10.1186/s13045-020-00853-x. View

18.

Lobbardi R, Pinder J, Martinez-Pastor B, Theodorou M, Blackburn J, Abraham B . TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia. Cancer Discov. 2017; 7(11):1336-1353. PMC: 5683427. DOI: 10.1158/2159-8290.CD-17-0267. View

19.

Kasakovski D, Xu L, Li Y . T cell senescence and CAR-T cell exhaustion in hematological malignancies. J Hematol Oncol. 2018; 11(1):91. PMC: 6032767. DOI: 10.1186/s13045-018-0629-x. View

20.

Zhang H, Zhao P, Huang H . Engineering better chimeric antigen receptor T cells. Exp Hematol Oncol. 2020; 9(1):34. PMC: 7709221. DOI: 10.1186/s40164-020-00190-2. View